InvestorsObserver is giving ProQR Therapeutics NV (PRQR) an Analyst Rating Rank of 17, meaning PRQR is ranked higher by analysts than 17% of stocks. The average price target for PRQR is $1.4 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating PRQR a Buy today. Find out what this means to you and get the rest of the rankings on PRQR!